Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Resolutions from Sobi's Annual General Meeting | ||||||||||
By: Nasdaq / GlobeNewswire - 30 Jun 2015 | Back to overview list |
|||||||||
The Swedish Orphan Biovitrum AB (publ) (Sobi) Annual General Meeting (AGM) convened earlier today in Stockholm and voted in favour of the resolutions proposed at the meeting, including:
Adoption of the profit and loss statements and balance sheet and discharge of liability
The board members and the chief executive officer were discharged from liability for the financial year 2014.
Election of Board of Directors, remuneration to the Directors and election of Auditor
The AGM approved the compensation to the Board in accordance with the nomination committee's proposal. Ernst & Young was elected as auditor of Sobi until the end of the annual general meeting 2016.
Principles for remuneration for the management, long-term incentive program and transfer of own shares
The AGM also approved the Board's proposal regarding the implementation of a long-term incentive program, and hedging arrangements in respect of the program including a directed issue of no more than 1,036,856 series C shares, authorisation for the Board to decide on a repurchase of all issued series C shares and transfers of no more than 1,630,976 own common shares to program participants. The Board's proposal regarding transfer of no more than 193,233 own common shares on the stock exchange for the purpose of covering certain payments, mainly social security contributions, that may occur in relation to the Share Program 2012, was also approved by the AGM. For full details on each proposal adopted by the AGM please refer to www.sobi.com . - - -
About Sobi
For more information please contact
The information was released for public distribution on June 30, 2015 at 16.15 p.m. CET.
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Swedish Orphan Biovitrum AB (publ) via GlobeNewswire
HUG#1933006
|
||||||||||
|
||||||||||
Copyright 2015 Nasdaq / GlobeNewswire | Back to overview list |